Abstract
BackgroundMany respiratory viruses disproportionately impact the elderly. Likewise, advanced age correlated with more adverse disease outcomes following severe acute respiratory syndrome coronavirus (SARS-CoV) infection in humans. We used an aged African green monkey SARS-CoV infection model to better understand age-related mechanisms of increased susceptibility to viral respiratory infections. Nonhuman primates are critical translational models for such research given their similarities to humans in immune-ageing as well as lung structure.ResultsSignificant age- and infection-dependent differences were observed in both systemic and mucosal immune compartments. Peripheral lymphocytes, specifically CD8 T and B cells were significantly lower in aged monkeys pre- and post- SARS-CoV infection, while neutrophil and monocyte numbers were not impacted by age or infection status. Serum proinflammatory cytokines were similar in both age groups, whereas significantly lower levels of IL-1beta, IL-18, IL-6, IL-12 and IL-15 were detected in the lungs of SARS-CoV-infected aged monkeys at either 5 or 10 days post infection. Total lung leukocyte numbers and relative frequency of CD8 T cells, B cells, macrophages and dendritic cells were greatly reduced in the aged host during SARS-CoV infection, despite high levels of chemoattractants for many of these cells in the aged lung. Dendritic cells and monocytes/macrophages showed age-dependent differences in activation and chemokine receptor profiles, while the CD8 T cell and B cell responses were significantly reduced in the aged host. In examination of viral titers, significantly higher levels of SARS-CoV were detected in the nasal swabs early, at day 1 post infection, in aged as compared to juvenile monkeys, but virus levels were only slightly higher in aged animals by day 3. Although there was a trend of higher titers in respiratory tissues at day 5 post infection, this did not reach statistical significance and virus was cleared from all animals by day 10, regardless of age.ConclusionsThis study provides unique insight into how several parameters of the systemic and mucosal immune response to SARS-CoV infection are significantly modulated by age. These immune differences may contribute to deficient immune function and the observed trend of higher SARS-CoV replication in aged nonhuman primates.
Highlights
Viral respiratory infections remain a predominant cause of morbidity and mortality in aged adults
SARS-CoV infection and clinical features in juvenile and aged monkeys To evaluate the impact of advanced age on severity of SARS-CoV infection, aged and juvenile African green monkeys were inoculated intranasally with 107 plaqueforming units (PFU) SARS-CoV HKU-39849 strain or mock-infected with sacrifice at 5 or 10 days post infection (d.p.i.)
We examined peripheral monocytes, dendritic cell (DC) and CD8 T cells for CCL5 and CCL20 receptor expression as these chemokines were found at highest concentrations in the aged lung
Summary
Viral respiratory infections remain a predominant cause of morbidity and mortality in aged adults. Several physiological parameters are thought to contribute to the poor outcomes of infectious disease in the elderly population, including the aging immune as well as respiratory system. Almost all components of the immune system have been shown to undergo age-associated restructuring that greatly impacts immune function [2,3,4,5]. The decline in immune function with age results in reduced vaccine efficacy, further enhancing susceptibility to infection in the elderly [6,7,8]. Age-associated alterations in the mucosal immune system are thought to occur at distinct times and in a distinct manner relative to systemic immunity [9]. Likewise, advanced age correlated with more adverse disease outcomes following severe acute respiratory syndrome coronavirus (SARS-CoV) infection in humans. Nonhuman primates are critical translational models for such research given their similarities to humans in immune-ageing as well as lung structure
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.